Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/03/23 → 6/03/28 |
A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately to Severely Active Ulcerative Colitis
- Moore, Gregory (Primary Chief Investigator (PCI))
Project: Research